Kilitch Drugs (India) (NSE:KILITCH) Total Inventories: ₹115 Mil (As of Mar. 2026)


NSE:KILITCH Kilitch Drugs (India) Ltd NSE:KILITCH
84 GF Score
Price ₹185.31
GF Value ₹225.33
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Kilitch Drugs (India) Total Inventories?

Kilitch Drugs (India) NSE:KILITCH -2.89% 84 Total Inventories is ₹115 Mil as of Mar. 2026. GuruFocus rates NSE:KILITCH with a GF Score™ of 84/100 and a GF Value™ of ₹225.33 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Kilitch Drugs (India)'s total inventories for the quarter that ended in Mar. 2026 was ₹115 Mil. Kilitch Drugs (India)'s average total inventories from the quarter that ended in Dec. 2025 to the quarter that ended in Mar. 2026 was ₹58 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Kilitch Drugs (India)'s Net-Net Working Capital per share for the quarter that ended in Mar. 2026 was ₹-3.84.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Kilitch Drugs (India)'s Days Inventory for the three months ended in Mar. 2026 was 11.90.

Inventory Turnover measures how fast the company turns over its inventory within a year. Kilitch Drugs (India)'s Inventory Turnover for the quarter that ended in Mar. 2026 was 7.67.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Kilitch Drugs (India)'s Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 0.06.

Kilitch Drugs (India)  (NSE:KILITCH) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Kilitch Drugs (India)'s Net-Net Working Capital Per Share for the quarter that ended in Mar. 2026 is

Net-Net Working Capital Per Share (Q: Mar. 2026 )
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(687.718+0.75 * 1201.771+0.5 * 115.207-1808.821
-0--27.862)/34.962
=-3.84

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Kilitch Drugs (India)'s Days Inventory for the three months ended in Mar. 2026 is calculated as:

Days Inventory=Average Total Inventories (Q: Mar. 2026 )/Cost of Goods Sold (Q: Mar. 2026 )*Days in Period
=57.6035/441.547*365 / 4
=11.90

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Kilitch Drugs (India)'s Inventory Turnover for the quarter that ended in Mar. 2026 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Mar. 2026 ) / Average Total Inventories (Q: Mar. 2026 )
=441.547 / 57.6035
=7.67

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Kilitch Drugs (India)'s Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Mar. 2026 ) / Revenue (Q: Mar. 2026 )
=57.6035 / 896.027
=0.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Kilitch Drugs (India) Total Inventories Related Terms

Kilitch Drugs (India) Total Inventories Historical Data

* Premium members only.

The historical data trend for Kilitch Drugs (India)'s Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kilitch Drugs (India) Total Inventories Chart

Kilitch Drugs (India) Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Inventories
Get a 7-Day Free Trial Premium Member Only Premium Member Only 52.88 24.07 55.82 215.78 115.21

Kilitch Drugs (India) Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Inventories Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 215.78 0.00 130.10 0.00 115.21
NSE:KILITCH
84GF Score
Kilitch Drugs (India) Ltd NSE:KILITCH
Total Inventories is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kilitch Drugs (India) Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Frequently Asked Questions Learn more about Total Inventories →
What does a Total Inventories of ₹115 Mil mean?
Kilitch Drugs (India) (NSE:KILITCH) has a Total Inventories of ₹115 Mil as of Mar. 2026. The total amount of inventory as recorded on a company's balance sheet. View historical data for Kilitch Drugs (India) and its competitors.
Is Kilitch Drugs (India)'s Total Inventories too high?
Kilitch Drugs (India)'s current Total Inventories is ₹115 Mil. Overall, Kilitch Drugs (India) has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Kilitch Drugs (India)'s Total Inventories compare to ZTS?
Kilitch Drugs (India)'s Total Inventories of ₹115 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Drug Manufacturers company?
A good Total Inventories depends on the Drug Manufacturers industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for Kilitch Drugs (India) and its competitors. Kilitch Drugs (India)'s current Total Inventories is ₹115 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kilitch Drugs (India) stock overvalued right now?
Based on GuruFocus' analysis, Kilitch Drugs (India) (NSE:KILITCH) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹225.33, compared to a current price of ₹185.31 — trading 17.8% below its estimated fair value. The current Total Inventories is ₹115 Mil. Kilitch Drugs (India)'s overall GF Score™ is 84/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For Kilitch Drugs (India) (NSE:KILITCH), the current Total Inventories is ₹115 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kilitch Drugs (India) (NSE:KILITCH) Overvalued in 2026?

Based on GuruFocus' analysis, Kilitch Drugs (India) stock appears to be undervalued. The current stock price of ₹185.31 is trading 17.8% below its estimated GF Value™ of ₹225.33. GuruFocus considers Kilitch Drugs (India) to be Modestly Undervalued.

Key valuation signals for NSE:KILITCH:

  • Total Inventories: ₹115 Mil
  • GF Value™: ₹225.33 vs. price of ₹185.31 (17.8% below fair value)
  • GF Score™: 84/100 with 4 warning signs

No single metric tells the full story. See the NSE:KILITCH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Kilitch Drugs (India) Business Description

Other Exchanges 524500:India
Address Waman Tukaram Patil Marg, 37/39, Ujagar Industrial Estate, Deonar, Mumbai, MH, IND, 400 088
Kilitch Drugs (India) Ltd is an India-based pharmaceutical company. It is engaged in operation and management of Pharmaceutical Products. The company offers parenteral and nasal products, oral formulations, effervescent tablets, nutritional products, medical devices, and cosmetic and health products. Some of the products offered by the company are Roipar, Roivit, PH-7, C-Seal, SRO kit, 9-VIT, and HPURE. The company has one reportable segment, which is the development and operations of the Pharmaceutical business.
84GF Score

Get the complete analysis for NSE:KILITCH

Total Inventories is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹185.31
Price
₹225.33
GF Value